NORTH HAVEN, Conn.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the worldwide launch of its proprietary Tri-Staple™ technology platform for endoscopic stapling. The first-of-its-kind technology enables surgeons to use staplers in a wider variety of laparoscopic procedures and in a broader range of tissue thicknesses than ever before.
